Advisory Commission on Childhood Vaccines; Notice of Meeting, 49275 [2013-19576]

Download as PDF 49275 Federal Register / Vol. 78, No. 156 / Tuesday, August 13, 2013 / Notices June 12, 2013, Vol. 78, No. 113; p. 35287. There were two public comments. One of the grantees recommended HRSA/ORHP eliminate the process measures and focus on outcome measures. HRSA is currently working on revising the measures for the entire program, and, as the grantee suggested, is attempting to focus the measures more on outcomes. As noted above, HRSA/ORHP’s intent in using the current measures until the next competitive grant cycle (July 2014) is to allow grantees to make adjustments to their data collection/data reporting systems, as well as revise the general program requirements to more closely align with the statute. There will also be another period for the general public to comment on the new measures. Another grantee requested a copy of the measures, seeking clarification on what was being asked. Clarification was provided that none of the measures will be changed this year. The measures have been the same for the last several years. Likely Respondents: Black Lung Clinics Program Grantees. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Number of responses per respondent Number of respondents Name of instrument ....... Black Lung Clinics Program Measures ............... 1 15 10.0 150.00 Total ........................ .............................................................................. 1 15 10.0 150.00 Dated: August 6, 2013. Bahar Niakan, Director, Division of Policy and Information Coordination. [FR Doc. 2013–19569 Filed 8–12–13; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration ehiers on DSK2VPTVN1PROD with NOTICES Advisory Commission on Childhood Vaccines; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Commission on Childhood Vaccines (ACCV). Date and Time: September 5, 2013, 10:00 a.m. to 4:00 p.m. EDT. Place: Audio Conference Call and Adobe Connect Pro. The ACCV will meet on Thursday, September 5 from 10:00 a.m. to 4:00 p.m. (EDT). The public can join the meeting by: 1. (Audio Portion) Calling the conference Phone Number 800–369– 3104 and providing the following information: Leaders Name: Dr. Vito Caserta Password: ACCV 2. (Visual Portion) Connecting to the ACCV Adobe Connect Pro Meeting using the following URL: https:// hrsa.connectsolutions.com/accv/ (copy VerDate Mar<15>2010 15:31 Aug 12, 2013 Jkt 229001 and paste the link into your browser if it does not work directly, and enter as a guest). Participants should call and connect 15 minutes prior to the meeting in order for logistics to be set up. If you have never attended an Adobe Connect meeting, please test your connection using the following URL: https://hrsa.connectsolutions.com/ common/help/en/support/ meeting_test.htm and get a quick overview by following URL: https:// www.adobe.com/go/ connectpro_overview. Call (301) 443–6634 or send an email to aherzog@hrsa.gov if you are having trouble connecting to the meeting site. Agenda: The agenda items for the September meeting will include, but are not limited to, updates from the Division of Vaccine Injury Compensation (DVIC); Department of Justice (DOJ); National Vaccine Program Office (NVPO); Immunization Safety Office (Centers for Disease Control and Prevention); National Institute of Allergy and Infectious Diseases (National Institutes of Health); and Center for Biologics, Evaluation and Research (Food and Drug Administration). A draft agenda and additional meeting materials will be posted on the ACCV Web site (https:// www.hrsa.gov/vaccinecompensation/ accv.htm) prior to the meeting. Agenda items are subject to change as priorities dictate. Public Comment: Persons interested in providing an oral presentation should submit a written request, along with a PO 00000 Frm 00026 Fmt 4703 Sfmt 9990 Total responses Average burden per response (in hours) Form name Total burden hours copy of their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 11C–26, 5600 Fishers Lane, Rockville, MD 20857 or email: aherzog@hrsa.gov. Requests should contain the name, address, telephone number, email address, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. DVIC will notify each presenter by email, mail or telephone of their assigned presentation time. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may announce it at the time of the public comment period. Public participation and ability to comment will be limited to space and time as it permits. FOR FURTHER INFORMATION CONTACT: Anyone requiring information regarding the ACCV should contact Annie Herzog, DVIC, HSB, HRSA, Room 11C–26, 5600 Fishers Lane, Rockville, MD 20857; Telephone (301) 443–6593 or email: aherzog@hrsa.gov. Dated: August 7, 2013. Bahar Niakan, Director, Division of Policy and Information Coordination. [FR Doc. 2013–19576 Filed 8–12–13; 8:45 am] BILLING CODE 4165–15–P E:\FR\FM\13AUN1.SGM 13AUN1

Agencies

[Federal Register Volume 78, Number 156 (Tuesday, August 13, 2013)]
[Notices]
[Page 49275]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-19576]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:
    Name: Advisory Commission on Childhood Vaccines (ACCV).
    Date and Time: September 5, 2013, 10:00 a.m. to 4:00 p.m. EDT.
    Place: Audio Conference Call and Adobe Connect Pro.
    The ACCV will meet on Thursday, September 5 from 10:00 a.m. to 4:00 
p.m. (EDT). The public can join the meeting by:
    1. (Audio Portion) Calling the conference Phone Number 800-369-3104 
and providing the following information:

Leaders Name: Dr. Vito Caserta
Password: ACCV

    2. (Visual Portion) Connecting to the ACCV Adobe Connect Pro 
Meeting using the following URL: https://hrsa.connectsolutions.com/accv/ (copy and paste the link into your browser if it does not work 
directly, and enter as a guest). Participants should call and connect 
15 minutes prior to the meeting in order for logistics to be set up. If 
you have never attended an Adobe Connect meeting, please test your 
connection using the following URL:
    https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and get a quick overview by following URL: https://www.adobe.com/go/connectpro_overview.
    Call (301) 443-6634 or send an email to aherzog@hrsa.gov if you are 
having trouble connecting to the meeting site.
    Agenda: The agenda items for the September meeting will include, 
but are not limited to, updates from the Division of Vaccine Injury 
Compensation (DVIC); Department of Justice (DOJ); National Vaccine 
Program Office (NVPO); Immunization Safety Office (Centers for Disease 
Control and Prevention); National Institute of Allergy and Infectious 
Diseases (National Institutes of Health); and Center for Biologics, 
Evaluation and Research (Food and Drug Administration). A draft agenda 
and additional meeting materials will be posted on the ACCV Web site 
(https://www.hrsa.gov/vaccinecompensation/accv.htm) prior to the 
meeting. Agenda items are subject to change as priorities dictate.
    Public Comment: Persons interested in providing an oral 
presentation should submit a written request, along with a copy of 
their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau 
(HSB), Health Resources and Services Administration (HRSA), Room 11C-
26, 5600 Fishers Lane, Rockville, MD 20857 or email: aherzog@hrsa.gov. 
Requests should contain the name, address, telephone number, email 
address, and any business or professional affiliation of the person 
desiring to make an oral presentation. Groups having similar interests 
are requested to combine their comments and present them through a 
single representative. The allocation of time may be adjusted to 
accommodate the level of expressed interest. DVIC will notify each 
presenter by email, mail or telephone of their assigned presentation 
time. Persons who do not file an advance request for a presentation, 
but desire to make an oral statement, may announce it at the time of 
the public comment period. Public participation and ability to comment 
will be limited to space and time as it permits.

FOR FURTHER INFORMATION CONTACT: Anyone requiring information regarding 
the ACCV should contact Annie Herzog, DVIC, HSB, HRSA, Room 11C-26, 
5600 Fishers Lane, Rockville, MD 20857; Telephone (301) 443-6593 or 
email: aherzog@hrsa.gov.

    Dated: August 7, 2013.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2013-19576 Filed 8-12-13; 8:45 am]
BILLING CODE 4165-15-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.